Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-373-3 | CAS number: 129909-90-6
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 Aug 1997 to 16 Sept 1997
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 410 (Repeated Dose Dermal Toxicity: 21/28-Day Study)
- Version / remarks:
- 1981)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 82-2 (Repeated Dose Dermal Toxicity -21/28 Days)
- Version / remarks:
- (1984)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3200 (Repeated Dose Dermal Toxicity -21/28 Days)
- Version / remarks:
- (1996)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF 59 NohSan No. 4200 (Guidance on toxicology study data for application of agriculture chemical registration) (1985)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 4-amino-N-tert-butyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide
- EC Number:
- 603-373-3
- Cas Number:
- 129909-90-6
- Molecular formula:
- C10H19N5O2
- IUPAC Name:
- 4-amino-N-tert-butyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide
- Reference substance name:
- Technical Grade MKH 3586
- IUPAC Name:
- Technical Grade MKH 3586
- Details on test material:
- - Name of test material (as cited in study report): Technical Grade MKH 3586
- Physical state: White powder
- Analytical purity: 98.2%
- Purity test date: October 1997
- Lot/batch No.: 05362/0005
- Expiration date of the lot/batch: 6 months from date of purity testing
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- F: 21 days = total of 17 applications
M: 22 days = total of 18 applications - Frequency of treatment:
- Animals were treated on 5 consecutive days (study days 0-4 and 7-11) during the first 2 weeks. For the 3rd week, females were treated on days 14-20 and males were treated on days 14-21.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 200, 500, 1000 mg/kg/day
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 10 animals/sex/dose group
- Control animals:
- yes, concurrent no treatment
Results and discussion
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 1 000 mg/kg bw/day (nominal)
- Based on:
- other: No evidence of toxicity observed
- Sex:
- male/female
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
OBSERVATIONS:
Clinical signs of toxicity:
No test material related clinical signs of toxicity were observed.
Bodyweight and bodyweight gain:
No test material related effects were observed.
Food consumption:
No test material related effects were observed.
Opthalmoscopic examination:
No test material related effects were observed.
Haematology & clinical chemistry:
No test material related effects were observed.
Sacrifice and Gross Pathology:
No gross lesions observed at necropsy.
Histopathology:
No test material related effects were observed.
Organ weights:
No test material related effects were observed.
Applicant's summary and conclusion
- Conclusions:
- Based on the results of this study, the NOAEL was 1000 mg/kg/day (the maximum recommended dose, in accordance with current guidelines). No evidence of toxicity was observed.
- Executive summary:
MKH 3582 was administeredviathe dermal route to Fischer F344 rats subjected to repeated dermal application under semi-occlusive conditions for 21 days on a 5 day/week basis during weeks 1 and 2 and daily from day 14 to 21. The exposure period was 6 hours/day. Test material doses of 0, 200, 500 and 1000 mg/kg/day were applied to 10 rats/sex/group.
The treatment produced no significant clinical signs, no effect on mean body weights or food consumption. No signs of irritation occurred at the application site. No ocular changes were seen and no effect on haematological parameters. Organ weights did not reveal any treatment related effects. Macroscopic post mortem examination did not indicate any treatment related changes.
Based on the results of this study, the NOAEL was 1000 mg/kg/day (the maximum recommended dose, in accordance with current guidelines). No evidence of toxicity was observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
